LXRX
Lexicon Pharmaceuticals Inc
NASDAQ: LXRX · HEALTHCARE · BIOTECHNOLOGY
$1.61
+3.87% today
Updated 2026-04-30
Market cap
$716.02M
P/E ratio
—
P/S ratio
14.38x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$1 – $2
Volume
2.4M
Lexicon Pharmaceuticals Inc (LXRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $218.71M | $190.27M | $369.30M | $261.51M | $257.76M | $366.88M | $430.51M | $371.78M | $274.16M | $471.38M | $654.83M | $475.63M | $436.54M | $284.14M | $417.71M | $203.79M | $136.91M | $194.30M | $229.43M | $298.42M |
| Cash & equivalents | $21.97M | $30.23M | $22.94M | $85.87M | $100.55M | $47.21M | $281.69M | $223.21M | $129.13M | $339.34M | $521.35M | $346.50M | $310.79M | $160.05M | $36.11M | $126.26M | $64.06M | $46.34M | $22.46M | $66.66M |
| Current assets | $106.05M | $85.55M | $264.65M | $109.17M | $169.68M | $214.74M | $281.69M | $230.94M | $134.55M | $368.99M | $532.40M | $357.87M | $322.00M | $173.32M | $337.75M | $157.72M | $88.92M | $140.87M | $176.55M | $246.19M |
| Total liabilities | $132.91M | $104.77M | $82.72M | $65.68M | $94.26M | $119.86M | $132.94M | $105.10M | $104.00M | $187.36M | $368.98M | $318.22M | $384.44M | $310.54M | $300.61M | $47.42M | $23.31M | $77.17M | $136.32M | $152.47M |
| Current liabilities | $57.46M | $45.97M | $35.35M | $21.18M | $50.95M | $10.78M | $24.89M | $18.29M | $19.29M | $44.97M | $123.00M | $164.64M | $124.13M | $36.75M | $65.34M | $46.81M | $22.12M | $23.17M | $31.55M | $45.25M |
| Long-term debt | $32.19M | $31.37M | $30.49M | $29.53M | $28.48M | $27.34M | $23.45M | $21.88M | $20.17M | $87.50M | $103.79M | $85.17M | $231.58M | $243.89M | $234.17M | — | — | $48.58M | $99.51M | $100.30M |
| Shareholder equity | $85.80M | $85.50M | $256.30M | $185.58M | $163.79M | $247.02M | $297.57M | $266.68M | $-1.00B | $284.02M | $285.85M | $157.40M | $52.10M | $-1.47B | $117.10M | $156.37M | $113.59M | $117.12M | $93.11M | $145.95M |
| Retained earnings | $-297.43M | $-351.74M | $-410.54M | $-487.39M | $-570.17M | $-673.41M | $-789.62M | $-899.83M | $-1.00B | $-1.10B | $-1.11B | $-1.25B | $-1.38B | $-1.47B | $-1.34B | $-1.40B | $-1.49B | $-1.59B | $-1.77B | $-1.97B |
| Accounts receivable | $2.61M | $1.19M | $1.76M | $568000.00 | $815000.00 | $744000.00 | $350000.00 | $1.38M | $790000.00 | $1.03M | $911000.00 | $7.49M | $4.83M | $5.92M | $56.53M | $395000.00 | $14000.00 | $28000.00 | $1.01M | $3.47M |
| Inventory | — | — | — | — | — | — | $-4.10M | $0.00 | $1.00 | $4.76M | $1.00 | $0.00 | $1.95M | $4.68M | $4.24M | $1.00 | — | $0.00 | $381000.00 | $231000.00 |
| Goodwill | $25.80M | $25.80M | $25.80M | $25.80M | $25.80M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M |